IDR 1060.0
(-2.3%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 559.46 Billion IDR | -32.07% |
2022 | 823.65 Billion IDR | -30.99% |
2021 | 1193.5 Billion IDR | 111.08% |
2020 | 565.43 Billion IDR | 56.4% |
2019 | 361.54 Billion IDR | 11.08% |
2018 | 325.47 Billion IDR | 35.73% |
2017 | 239.78 Billion IDR | 15.71% |
2016 | 207.22 Billion IDR | 6.47% |
2015 | 194.63 Billion IDR | 26.82% |
2014 | 153.47 Billion IDR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q3 | 242.75 Billion IDR | -0.25% |
2024 Q2 | 243.36 Billion IDR | 14.8% |
2024 Q1 | 211.99 Billion IDR | 33.84% |
2023 Q3 | 138.45 Billion IDR | 4.41% |
2023 FY | 559.46 Billion IDR | -32.07% |
2023 Q1 | 130 Billion IDR | 48.44% |
2023 Q2 | 132.6 Billion IDR | 2.0% |
2023 Q4 | 158.39 Billion IDR | 14.4% |
2022 Q2 | 266.89 Billion IDR | -26.12% |
2022 Q3 | 107.95 Billion IDR | -59.55% |
2022 Q4 | 87.58 Billion IDR | -18.88% |
2022 FY | 823.65 Billion IDR | -30.99% |
2022 Q1 | 361.22 Billion IDR | -0.04% |
2021 Q3 | 359.84 Billion IDR | 41.27% |
2021 FY | 1193.5 Billion IDR | 111.08% |
2021 Q4 | 361.35 Billion IDR | 0.42% |
2021 Q1 | 217.57 Billion IDR | -1.53% |
2021 Q2 | 254.72 Billion IDR | 17.07% |
2020 Q1 | 96.81 Billion IDR | 2.63% |
2020 Q2 | 95.81 Billion IDR | -1.04% |
2020 FY | 565.43 Billion IDR | 56.4% |
2020 Q4 | 220.96 Billion IDR | 45.52% |
2020 Q3 | 151.84 Billion IDR | 58.48% |
2019 Q4 | 94.33 Billion IDR | 3.19% |
2019 FY | 361.54 Billion IDR | 11.08% |
2019 Q3 | 91.41 Billion IDR | 4.18% |
2019 Q2 | 87.74 Billion IDR | -0.36% |
2019 Q1 | 88.06 Billion IDR | 3.57% |
2018 Q3 | 84.99 Billion IDR | 10.41% |
2018 FY | 325.47 Billion IDR | 35.73% |
2018 Q4 | 85.02 Billion IDR | 0.03% |
2018 Q1 | 78.47 Billion IDR | 26.58% |
2018 Q2 | 76.98 Billion IDR | -1.9% |
2017 FY | 239.78 Billion IDR | 15.71% |
2017 Q1 | 50.63 Billion IDR | -6.39% |
2017 Q2 | 55.15 Billion IDR | 8.91% |
2017 Q3 | 72 Billion IDR | 30.55% |
2017 Q4 | 61.99 Billion IDR | -13.9% |
2016 Q3 | 52.51 Billion IDR | 4.4% |
2016 FY | 207.22 Billion IDR | 6.47% |
2016 Q2 | 50.3 Billion IDR | -0.0% |
2016 Q1 | 50.3 Billion IDR | 0.0% |
2016 Q4 | 54.09 Billion IDR | 3.01% |
2015 FY | 194.63 Billion IDR | 26.82% |
2014 FY | 153.47 Billion IDR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
PT Hetzer Medical Indonesia Tbk | 22.72 Billion IDR | -2362.092% |
PT Jayamas Medica Industri Tbk | 1736.98 Billion IDR | 67.791% |
Maja Agung Latexindo Tbk. | 81.71 Billion IDR | -584.632% |